About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Molecular Diagnosis of Allergic Contact Dermatitis | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06177314

Molecular Diagnosis of Allergic Contact Dermatitis

Allergic contact dermatitis (ACD) is a common inflammatory skin disease, affecting approximately 15-20% of the general population in industrialized countries and ranking first among occupational disea...

Lead sponsor: Hospices Civils de Lyon•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Audrey NOSBAUM, MD, PhD

CONTACT

04 78 86 12 85 Audrey.nosbaum@chu-lyon.fr

Marine-Alexia LEFEVRE, MD, PhD

CONTACT

Marine-alexia.lefevre@inserm.fr

Sponsors

Lead Sponsor

Hospices Civils de Lyon

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient, male or female, over 18 years of age
•Patient with active contact dermatitis lesion biopsied for molecular analysis
•Patients who have undergone patch testing
•Patients whose positive patch tests were biopsied for molecular analysis
•Written informed consent given prior to any study-related procedure
•Between 01/01/2020 and 31/12/2025

Exclusion Criteria

•Missing clinical data
•Patient objecting to use of data

Related studies

Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

NCT07183423 · Psoriasis, Atopic Dermatitis, and more

Enrolling By InvitationNA

Rate of Allergic Contact Dermatitis and Cosmetic Outcomes

NCT06957444 · Allergic Contact Dermatitis, Osteoarthritis, Hip, and more

Active Not Recruiting

Methotrexat to Hand Eczema in the BIOSKIN Cohort

NCT07338305 · Atopic Dermatitis, Contact Dermatitis, and more

Not Yet RecruitingNA

Glycyrrhetinic Acid and Acute Irritant Dermatitis

NCT07286487 · Irritant Contact Dermatitis

DermAI to Evaluate Human Factor of Testing

NCT06387472 · Contact Dermatitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 20, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment80

Start dateApr 2023

Last updatedDec 20, 2023

Condition

Contact Dermatitis Contact Dermatitis Irritant Contact Dermatitis, Allergic

Locations shown

Centre Hospitalier Lyon Sud

Pierre-Bénite

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions